Idexx Laboratories (IDXX) Total Liabilities (2009 - 2026)

Idexx Laboratories' Total Liabilities history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Total Liabilities rose 3.61% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $1.8 billion (up 3.61% YoY), while the FY2025 annual figure was $1.7 billion, up 2.78% from the prior year.
• Total Liabilities was $1.8 billion for Q1 2026 at Idexx Laboratories, up from $1.7 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.2 billion in Q3 2022 to a low of $1.7 billion in Q4 2024.
• Historically, Total Liabilities has averaged $1.9 billion across 5 years, with a median of $1.8 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities surged 32.74% in 2022, then fell 17.36% in 2023.
• A 5-year view of Total Liabilities shows it stood at $2.1 billion in 2022, then slipped by 16.96% to $1.8 billion in 2023, then declined by 4.35% to $1.7 billion in 2024, then increased by 2.78% to $1.7 billion in 2025, then rose by 4.81% to $1.8 billion in 2026.
• The last three Total Liabilities figures came in at $1.8 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.